Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03364400
Title Phase 1 Study Evaluating VT1021 in Patients With Advanced Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Vigeo Therapeutics, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Florida Cancer Specialists Sarasota Florida 34232 United States Details
Northwestern Memorial Hospital Chicago Illinois 60611 United States Details
Horizon Oncology Center Lafayette Indiana 47905 United States Details
The Johns Hopkins Hospital Baltimore Maryland 21287 United States Details
Massachusetts General Hospital Boston Massachusetts 02114 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02115 United States Details
Beth Israel Boston Massachusetts 02215 United States Details
Case Western Reserve University Cleveland Ohio 44106 United States Details
Cleveland Clinic Cleveland Ohio 44195 United States Details
University of Oklahoma Oklahoma City Oklahoma 73104 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
START San Antonio Texas 78229 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field